Home › Funds › Conestoga Capital Advisors, LLC › AGYS

Conestoga Capital Advisors, LLC position in AGYS

AGILYSYS INC · Technology

Conestoga Capital Advisors, LLC reported holding 385,294 shares of AGYS (AGILYSYS INC) in its Q3 2026 13F filing — a position valued at US$37.4M, representing 1.13% of its reported portfolio and ranking #31 among its reported holdings. Conestoga Capital Advisors, LLC has disclosed AGYS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)385.29K sh
Reported value held$37.40M
Portfolio Weight1.13%
First reportedQ2 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Conestoga Capital Advisors, LLC's AGYS position evolved

Conestoga Capital Advisors, LLC first disclosed a stake in AGYS in Q2 2024 at 158,878 shares (US$16.5M). The position peaked in Q2 2025 at 732,264 shares, worth US$83.9M. Across 10 filings, Conestoga Capital Advisors, LLC increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 385,294 shares valued at US$37.4M — a reduction of -91,260 shares quarter over quarter.. Notable position changes include a 79% increase in Q3 2024 (shares rose 21% over the following quarter), a 105% increase in Q1 2025 (shares rose 58% over the following quarter), a 30% trim in Q2 2026 (shares fell 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 158.88K $16.55M New
Q3 2024 285.07K $31.06M Add
Q4 2024 356.24K $46.92M Add
Q1 2025 731.04K $53.03M Add
Q2 2025 732.26K $83.95M Hold
Q3 2025 655.78K $69.02M Reduce
Q4 2025 598.14K $71.08M Reduce
Q1 2026 683.74K $48.64M Add
Q2 2026 476.55K $49.80M Reduce
Q3 2026 385.29K $37.40M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AGYS and 13F data

AGYS (AGILYSYS INC) is a Technology company. 34 other funds we track also report a position in AGYS — the largest reported positions include MAK CAPITAL ONE LLC (US$124.6M), AltraVue Capital, LLC (US$53.5M), GENEVA CAPITAL MANAGEMENT LLC (US$45.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AGYS

All AGYS fund holders →

FAQ

How long has Conestoga Capital Advisors, LLC held AGYS?

Conestoga Capital Advisors, LLC has disclosed AGYS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Conestoga Capital Advisors, LLC's current position in AGYS?

As of Q3 2026, Conestoga Capital Advisors, LLC holds 385.29K shares of AGYS (AGILYSYS INC), valued at $37.40M, representing 1.13% of its reported portfolio and ranking #31.

Has Conestoga Capital Advisors, LLC been buying or selling AGYS?

In the latest 13F filing (Q3 2026), Conestoga Capital Advisors, LLC reduced its position in AGYS. The position peaked in Q2 2025 at 732.26K shares.

Which other funds hold AGYS?

Other major institutional holders of AGYS include MAK CAPITAL ONE LLC, AltraVue Capital, LLC, GENEVA CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.